Low-rate severe adverse events should be recognised as an ethically significant potential outcome of innovation in surgery.

Addressing epistemic injustice (a pattern of ignoring, or being unable to understand, the testimony of patients) is a key ethical challenge for evaluating the use of surgical innovations such as transvaginal mesh (TVM).

Women should be acknowledged as knowledge holders and agents in their experience of TVM surgery.